Literature DB >> 27344576

Antifungal prophylaxis: update on an old strategy.

A Cortegiani1, V Russotto2, S M Raineri2, A Giarratano2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27344576     DOI： 10.1007/s10096-016-2699-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  7 in total

1.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

2.  Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.

Authors:  Andrew F Shorr; Kevin Chung; William L Jackson; Paige E Waterman; Marin H Kollef
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

3.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

Authors:  Drosos E Karageorgopoulos; Evridiki K Vouloumanou; Fotinie Ntziora; Argyris Michalopoulos; Petros I Rafailidis; Matthew E Falagas
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

4.  (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.

Authors:  Brunella Posteraro; Mario Tumbarello; Gennaro De Pascale; Elvira Liberto; Maria S Vallecoccia; Elena De Carolis; Valentina Di Gravio; Enrico M Trecarichi; Maurizio Sanguinetti; Massimo Antonelli
Journal:  J Antimicrob Chemother       Date:  2016-04-28       Impact factor: 5.790

Review 5.  Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Alessandra Maggiore; Massimo Attanasio; Alessandro R Naro; Santi Maurizio Raineri; Antonino Giarratano
Journal:  Cochrane Database Syst Rev       Date:  2016-01-16

Review 6.  Invasive candidiasis: from mycobiome to infection, therapy, and prevention.

Authors:  L Lagunes; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-04       Impact factor: 3.267

7.  The paradox of the evidence about invasive fungal infection prevention.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Santi Maurizio Raineri; Antonino Giarratano
Journal:  Crit Care       Date:  2016-04-27       Impact factor: 9.097
  7 in total
  5 in total

1.  Should we Administer Antifungal Drugs Before the Diagnosis of Invasive Fungal Infection in Non-Neutropenic Critically Ill Patients?

Authors:  Andrea Cortegiani; Vincenzo Russotto; Santi Maurizio Raineri; Cesare Gregoretti; Antonino Giarratano
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-12-01

2.  Dying with or Because of Invasive Fungal Infection? The Role of Immunity Exhaustion on Patient Outcome.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Santi Maurizio Raineri; Cesare Gregoretti; Antonino Giarratano
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-12-01

3.  Lessons from uncertainty on antifungal treatment in ICU.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Antonino Giarratano
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  Effect of empirical antifungal treatment on mortality in non-neutropenic critically ill patients: a propensity-matched retrospective cohort study.

Authors:  Yue Tang; Wenjing Hu; Shuangyan Jiang; Maoyu Xie; Wenying Zhu; Lin Zhang; Jing Sha; Tengfei Wang; Min Ding; Juan Zeng; Jinjiao Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-10-18       Impact factor: 5.103

5.  Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?

Authors:  A Cortegiani; V Russotto; S M Raineri; G Gregoretti; A Giarratano
Journal:  Crit Care       Date:  2016-10-30       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.